TD Cowen Boosts TransMedics Price Target to $120 on Strong Transplant Growth
Accelerating U.S. heart, liver & lung transplants plus strong flight data signal major growth ahead.
/ 2 items
Accelerating U.S. heart, liver & lung transplants plus strong flight data signal major growth ahead.
TransMedics shares dropped after FDA clearance of a rival liver perfusion system, but TD Cowen says the selloff is overdone and sees no real competitive threat.